Your browser doesn't support javascript.
loading
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.
Francis, Joshua M; Leistritz-Edwards, Del; Dunn, Augustine; Tarr, Christina; Lehman, Jesse; Dempsey, Conor; Hamel, Andrew; Rayon, Violeta; Liu, Gang; Wang, Yuntong; Wille, Marcos; Durkin, Melissa; Hadley, Kane; Sheena, Aswathy; Roscoe, Benjamin; Ng, Mark; Rockwell, Graham; Manto, Margaret; Gienger, Elizabeth; Nickerson, Joshua; Moarefi, Amir; Noble, Michael; Malia, Thomas; Bardwell, Philip D; Gordon, William; Swain, Joanna; Skoberne, Mojca; Sauer, Karsten; Harris, Tim; Goldrath, Ananda W; Shalek, Alex K; Coyle, Anthony J; Benoist, Christophe; Pregibon, Daniel C.
Affiliation
  • Francis JM; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Leistritz-Edwards D; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Dunn A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Tarr C; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Lehman J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Dempsey C; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Hamel A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Rayon V; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Liu G; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Wang Y; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Wille M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Durkin M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Hadley K; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Sheena A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Roscoe B; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Ng M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Rockwell G; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Manto M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Gienger E; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Nickerson J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Moarefi A; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Noble M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Malia T; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Bardwell PD; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Gordon W; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Swain J; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Skoberne M; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Sauer K; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Harris T; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Goldrath AW; Division of Biological Sciences, Molecular Biology Section, University of California, San Diego, San Diego, CA, USA.
  • Shalek AK; Repertoire Immune Medicines, Cambridge, MA, USA.
  • Coyle AJ; Department of Chemistry and Koch Institute for Integrative Cancer Research, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Benoist C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Pregibon DC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Sci Immunol ; 7(67): eabk3070, 2022 01 21.
Article de En | MEDLINE | ID: mdl-34793243
ABSTRACT
Effective presentation of antigens by human leukocyte antigen (HLA) class I molecules to CD8+ T cells is required for viral elimination and generation of long-term immunological memory. In this study, we applied a single-cell, multiomic technology to generate a unified ex vivo characterization of the CD8+ T cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across four major HLA class I alleles. We found that HLA genotype conditions key features of epitope specificity, TCRα/ß sequence diversity, and the utilization of pre-existing SARS-CoV-2-reactive memory T cell pools. Single-cell transcriptomics revealed functionally diverse T cell phenotypes of SARS-CoV-2-reactive T cells, associated with both disease stage and epitope specificity. Our results show that HLA variations notably influence the CD8+ T cell repertoire shape and utilization of immune recall upon SARS-CoV-2 infection.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigènes d'histocompatibilité de classe I / Récepteur lymphocytaire T antigène, alpha-bêta / Lymphocytes T CD8/ / Allèles / SARS-CoV-2 / COVID-19 / Cellules T mémoire Limites: Humans Langue: En Journal: Sci Immunol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antigènes d'histocompatibilité de classe I / Récepteur lymphocytaire T antigène, alpha-bêta / Lymphocytes T CD8/ / Allèles / SARS-CoV-2 / COVID-19 / Cellules T mémoire Limites: Humans Langue: En Journal: Sci Immunol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique